Arca
Skip to content
Tools
Tools

Voltage-gated calcium channel

Complex group in Homo sapiens that 9 drugs act on.

  • Drugs that act on it: 9
  • Approved: 6
  • In phases 1 to 3: 3
  • Sponsors: 3
  • Genes: 26

Who is on it, and how far along

Every drug ChEMBL records acting on CACNA1A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 9

Approved6

  • Pregabalin
  • Gabapentin
  • Gabapentin enacarbil
  • Bepridil
  • Suloctidil
  • Terodiline

Phase 32

  • Imagabalin
  • Phloroglucinol

Phase 21

  • Atagabalin

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    The landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 5 of 9 act as: Voltage-gated calcium channel modulator; the rest name their own mechanism.
    PregabalinApprovedViatrisSmall moleculeModulator85
    GabapentinApprovedViatrisSmall moleculeModulator70
    Gabapentin enacarbilApprovedAzurity PharmaceuticalsSmall moleculeModulator68
    BepridilApprovedViatrisSmall moleculeBlockerVoltage-gated calcium channel blocker1
    SuloctidilWithdrawnApproved—Small moleculeBlockerVoltage-gated calcium channel blocker0
    TerodilineWithdrawnApproved—Small moleculeBlockerVoltage-gated calcium channel blocker0
    ImagabalinPhase 3PfizerSmall moleculeModulator0
    PhloroglucinolPhase 3—Small moleculeBlockerVoltage-gated calcium channel blocker0
    AtagabalinPhase 2PfizerSmall moleculeModulator0

    Open trials

    The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 17 in all, from ClinicalTrials.gov.
    Effect of GABAergic Treatments on Cortical Plasticity and Motor Learning Capacity in the Subacute Phase After StrokeGabapentin, Gabapentin enacarbilNot applicableNot yet recruitingUniversity Hospital, ToulouseNov 17, 2026
    Prolonged Multimodal Analgesia for Postsurgical PainPregabalinNot applicableNot yet recruitingBeijing Tiantan HospitalNov 13, 2026
    Physical Therapy for the Management of Postoperative Pain After Minimally Invasive Thoracic SurgeryGabapentin, Gabapentin enacarbilPhase 4Not yet recruitingUniversity of MiamiNov 12, 2026
    Efficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic PainPregabalin—RecruitingHK inno.N CorporationNov 12, 2026
    Effectiveness of Phenotype-based Pain Management Guidelines for Head and Neck Cancer Related Pain: a Pilot StudyPregabalinPhase 2RecruitingShaukat Khanum Memorial Cancer Hospital & Research CentreNov 5, 2026
    Phenotype-based Model for Managing Chronic Post-treatment Pain Among Head and Neck Cancer Survivors: a Pilot StudyPregabalinPhase 2RecruitingShaukat Khanum Memorial Cancer Hospital & Research CentreNov 5, 2026
    Oral Gabapentin Versus Intravenous Neostigmine/Atropine Versus Combination of Both for Prevention of PDPHGabapentin, Gabapentin enacarbilPhase 2 / Phase 3RecruitingAssiut UniversityNov 4, 2026
    A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.PregabalinPhase 2RecruitingTavo BiotherapeuticsNov 3, 2026
    Comparison of Two Postoperative Care Strategies After Breast SurgeryPregabalinNot applicableRecruitingMoumtzidou Maria AikateriniOct 19, 2026
    Suzetrigine for Analgesiain Arthroscopic Rotator Cuff RepairGabapentin, Gabapentin enacarbilPhase 4Not yet recruitingUniversity of Alabama at BirminghamOct 8, 2026
    Acute Post-Amputation Pain Management After Combat-Related Lower Limb InjuryPregabalinNot applicableNot yet recruitingKharkiv National Medical UniversityOct 7, 2026
    Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILDGabapentin, Gabapentin enacarbilPhase 4Not yet recruitingPost Graduate Institute of Medical Education and Research, ChandigarhOct 6, 2026
    Mechanistic Evaluation of Polypharmacy Effects for PainGabapentin, Gabapentin enacarbilPhase 1 / Phase 2Not yet recruitingUniversity of Maryland, BaltimoreSep 29, 2026
    Epidural Analgesia Versus Opioid-sparing Analgesia for Open Ventral Hernia Repair With Transversus Abdominis ReleaseGabapentin, Gabapentin enacarbilPhase 4RecruitingNorthwestern UniversitySep 24, 2026
    Pregabalin for Chronic Pelvic Pain in WomenPregabalinNot applicableNot yet recruitingBeijing Tiantan HospitalSep 14, 2026
    Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid UsersGabapentin, Gabapentin enacarbilPhase 4RecruitingViatris Inc.Sep 10, 2026
    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort StudyBepridil—Not yet recruitingFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineDec 4, 2025

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363032, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

    Esc

    Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

    Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.